Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
Apply
Vactosertib
Oral TGF-beta Receptor I Inhibitor Vactosertib in SOC Chemoradiotherapy for Esophageal Adenocarcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step